Efficacy of tacrolimus and i.v.[intravenous] -immunoglobulins in Rasmussen encephalitis with start of treatment in the acute disease stage. prospective, randomised, open parallel group study

Trial Profile

Efficacy of tacrolimus and i.v.[intravenous] -immunoglobulins in Rasmussen encephalitis with start of treatment in the acute disease stage. prospective, randomised, open parallel group study

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 18 Apr 2009

At a glance

  • Drugs Immunoglobulins; Tacrolimus
  • Indications Encephalitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Dec 2008 Planned number of patients identified as 16 from ClinicalTrials.gov.
    • 01 Dec 2008 Planned end date identified as 1 Jul 2010 from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top